HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Muhammad A Geelani Sandeep Singh Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Geelani, M. A Articles by Nigam, M. Search for Related Content PubMed PubMed Citation Articles by Geelani, M. A Articles by Nigam, M. Related Collections Diaphragm

Anticoagulation in Patients with Mechanical Valves During Pregnancy

Department of Cardiothoracic and Vascular Surgery, GB Pant Hospital, New Delhi, India

For reprint information contact: Muhammad A Geelani, MCh Tel: 91 11 2205 9248 Fax: 91 11 2323 9442 Email: mageelani{at}hotmail.com, Department of Cardiothoracic and Vascular Surgery, GB Pant Hospital, New Delhi 110002, India.

Mechanical valve thrombosis is a life-threatening event, while pregnancy is associated with a hypercoagulable state. Thus, in pregnant women with mechanical valves, adequate anticoagulation becomes even more critical. This prospective study was conducted to establish a uniform anticoagulation regimen for these women. A total of 250 pregnancies in 245 women with mechanical heart valves were evaluated. The patients were divided into 2 groups: group 1 (n = 150) took oral warfarin throughout pregnancy and group 2 (n = 100) received subcutaneous heparin in the 1^st trimester and oral warfarin for the other trimesters. Both groups received heparin at the time of delivery. There were no coumarin-induced fetal malformations. Minor thromboembolic episodes took place in 5 women in group 1 and 3 in group 2. Valve thrombosis occurred in 1 woman in group 2 and led to 1 maternal death in this series. The incidence of spontaneous abortion was similar between the groups. We conclude that warfarin is safe and convenient to use during pregnancy. The teratogenic effects of warfarin during the 1^st trimester are overstated, and switching to heparin is not mandatory.

This article has been cited by other articles:

				S. M. Bates, I. A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 844S - 886S. [Abstract] [Full Text] [PDF]

				R. P Akhtar, A. R Abid, H. Zafar, M. A Cheema, and J. S Khan Anticoagulation in Pregnancy with Mechanical Heart Valves: 10-Year Experience Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 497 - 501. [Abstract] [Full Text] [PDF]

				Z. Al Halees MECHANICAL VALVES AND PREGNANCY: A CAVEAT Asian Cardiovasc Thorac Ann, June 1, 2006; 14(3): 264 - 264. [Full Text] [PDF]

				E. M Elmistekawy Warfarin Phobia Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 401 - 401. [Full Text] [PDF]